glp-1 adoption US households with users cut their grocery spending India's GLP-1 Adoption Lags Despite

This story was produced by GoodRx and reviewed and distributed by Stacker .

(2025) 388:q2440

Noom also introduced Glucose Forecasting in November 2025, which predicts the glucose impact of meals without requiring CGM hardware, available to enterprise and select consumer members

For research-peptide users, this is the single most important data drop since the original NEJM Phase 2 paper by Jastreboff and colleagues in 2023

Thyroid considerations Animal studies with GLP-1 class agents have raised questions about thyroid C-cell tumours, which is why individuals with a history of medullary thyroid carcinoma or MEN2 are excluded from trials